company background image
532321 logo

Zydus Lifesciences BSE:532321 Stock Report

Last Price

₹972.60

Market Cap

₹979.3b

7D

-2.9%

1Y

58.7%

Updated

07 Nov, 2024

Data

Company Financials +

Zydus Lifesciences Limited

BSE:532321 Stock Report

Market Cap: ₹979.3b

532321 Stock Overview

Engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally.

532321 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends4/6

Zydus Lifesciences Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zydus Lifesciences
Historical stock prices
Current Share Price₹972.60
52 Week High₹1,323.90
52 Week Low₹602.10
Beta0.42
11 Month Change-7.74%
3 Month Change-25.27%
1 Year Change58.73%
33 Year Change97.64%
5 Year Change315.29%
Change since IPO15,018.30%

Recent News & Updates

Recent updates

Shareholder Returns

532321IN PharmaceuticalsIN Market
7D-2.9%3.0%1.6%
1Y58.7%54.1%36.9%

Return vs Industry: 532321 exceeded the Indian Pharmaceuticals industry which returned 54.1% over the past year.

Return vs Market: 532321 exceeded the Indian Market which returned 36.9% over the past year.

Price Volatility

Is 532321's price volatile compared to industry and market?
532321 volatility
532321 Average Weekly Movement3.6%
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.3%
10% least volatile stocks in IN Market4.0%

Stable Share Price: 532321 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 532321's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
195226,921Sharvil Patelzyduslife.com

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Consumer Products. It offers finished dosage human formulations, such as generics; branded generics; specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; animal healthcare products; and products in the therapeutic areas of pain management, neurology, metabolic disorder, and liver diseases.

Zydus Lifesciences Limited Fundamentals Summary

How do Zydus Lifesciences's earnings and revenue compare to its market cap?
532321 fundamental statistics
Market cap₹979.32b
Earnings (TTM)₹41.69b
Revenue (TTM)₹206.15b

23.5x

P/E Ratio

4.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
532321 income statement (TTM)
Revenue₹206.15b
Cost of Revenue₹63.05b
Gross Profit₹143.10b
Other Expenses₹101.41b
Earnings₹41.69b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 12, 2024

Earnings per share (EPS)41.43
Gross Margin69.41%
Net Profit Margin20.22%
Debt/Equity Ratio3.7%

How did 532321 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

8%

Payout Ratio